Klotho Neurosciences Proposes Reverse Stock Split to Avoid Nasdaq Delisting and Seeks Significant Equity Plan Expansion

summarizeSummary

Klotho Neurosciences is seeking shareholder approval for a reverse stock split to regain Nasdaq compliance and a substantial increase in its equity incentive plan, signaling efforts to address listing requirements and future compensation needs amidst high potential dilution.

check_boxKey Events

• Reverse Stock Split Proposed

  Shareholders will vote on a reverse stock split with a ratio between 1-for-2 and 1-for-50, aimed at increasing the per-share price to meet Nasdaq's $1.00 minimum bid price requirement.

• Equity Incentive Plan Expansion

  The company proposes to increase the shares reserved for its 2024 Equity Incentive Plan by 8,331,874, bringing the total to 10,000,000 shares, representing approximately 13.3% potential dilution of current outstanding shares.

• Nasdaq Delisting Threat

  Klotho Neurosciences received a delinquency notification from Nasdaq on September 19, 2025, for non-compliance with the minimum bid price requirement, making the reverse split critical for continued listing.

• High Projected Burn Rate

  The company projects an annual burn rate of 50% for its equity compensation, indicating a rapid rate of share issuance from the incentive plan.

auto_awesomeAnalysis

Klotho Neurosciences is proposing a reverse stock split with a broad ratio range (1-for-2 to 1-for-50) to address a Nasdaq deficiency for failing to meet the $1.00 minimum bid price. This action, while crucial for maintaining its listing, often signals underlying financial challenges and is typically viewed negatively by the market. Concurrently, the company seeks to increase its equity incentive plan by 8.3 million shares, which represents approximately 13.3% potential dilution of current outstanding shares. The projected 50% annual burn rate for equity compensation further underscores a heavy reliance on equity, which could lead to substantial dilution for existing shareholders. Investors should closely monitor the effectiveness of the reverse split in sustaining the stock price and the ongoing dilutive impact of the expanded equity plan.